Sensata Technologies B.V. Aug 10

  • ID: 2127379
  • August 2010
  • Standard & Poors
1 of 3


  • Sensata Technologies B.V.
  • Texas Instruments Inc.
  • MORE

Leading market positions and high operating margins Good product and end-market diversity Aggressive financial risk profile Participation in cyclical end markets Standard & Poor's Ratings Services' ratings on sensors and controls manufacturer Sensata Technologies B.V. (Sensata) reflect its aggressive financial risk profile and fair business risk profile. We believe business trends remain favorable, but are likely to moderate from the firm's recent high growth levels. Still, we expect Sensata to continue generating further revenue organically as its products are increasingly used in end-market applications. Furthermore, we expect the company's operating margin, before depreciation and amortization (D&A), will remain close to 30%. This may allow Sensata to sustain a funds from operations (FFO)-to-adjusted debt ratio of more than 15% (versus the...

Companies mentioned in this report are:
- Sensata Technologies B.V.
- Texas Instruments Inc.

Action: Review

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

- Sensata Technologies B.V.
- Texas Instruments Inc.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.